Biotech

GeoPharma Soars After Results

 

GeoPharma(GORX), a drug and nutritional-supplement maker, saw its shares jump after it announced positive quarterly results Tuesday.

GeoPharma earned $793,000, or 7 cents a share, in the second quarter, up from $514,000 and 4 cents a share a year ago. Excluding certain items, the company would have reported earnings of $1.2 million, or 9 cents a share, in the most recent quarter.

Revenue for the quarter reached $16.7 million, up 36.5% from a year ago.

Shares gained 10.3% to $4.29 on much-heavier-than-normal trading. The stock had been as high as $4.64 earlier in the session.

"GeoPharma has now achieved six straight quarters of consistent profitability and record revenues," said CEO Mihir Taneja in a prepared statement. "We are encouraged by the growth of each of our business segments and look forward to receiving [abbreviated new drug application] approvals from the [Food and Drug Administration] which will only further our growth from an income and revenue standpoint."

>To order reprints of this article, click here: Reprints

TheStreet Premium Services

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,393.45 1,310.33 2,827.34 15.81
Oil *
101.78
DOWN
26.41
DOWN
2.99
DOWN
10.02
DOWN
0.44
10 Yr
1.58%
SPDR Gold
151.62
-0.21%
-0.23%
-0.35%
-2.71%
Data delayed 20 minutes

Top Stories and Tools

Articles From

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet